167 related articles for article (PubMed ID: 12544370)
21. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
[TBL] [Abstract][Full Text] [Related]
22. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial.
Kozarić-Kovacić D; Pivac N; Mück-Seler D; Rothbaum BO
J Clin Psychiatry; 2005 Jul; 66(7):922-7. PubMed ID: 16013909
[TBL] [Abstract][Full Text] [Related]
23. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
Villeneuve E; Lemelin S
J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
[TBL] [Abstract][Full Text] [Related]
24. Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial.
Sacchetti E; Panariello A; Regini C; Valsecchi P
Schizophr Res; 2004 Aug; 69(2-3):325-31. PubMed ID: 15469204
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
Bellino S; Paradiso E; Bogetto F
J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
[TBL] [Abstract][Full Text] [Related]
26. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
Arvanitis LA; Miller BG
Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
[TBL] [Abstract][Full Text] [Related]
27. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Liebowitz M; Lam RW; Lepola U; Datto C; Sweitzer D; Eriksson H
Depress Anxiety; 2010 Oct; 27(10):964-76. PubMed ID: 20734365
[TBL] [Abstract][Full Text] [Related]
31. Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder.
Villarreal G; Hamner MB; Qualls C; Cañive JM
Psychopharmacol Bull; 2018 Feb; 48(2):8-17. PubMed ID: 29713096
[TBL] [Abstract][Full Text] [Related]
32. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
Kasper S; Brecher M; Fitton L; Jones AM
Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701
[TBL] [Abstract][Full Text] [Related]
33. Add-on quetiapine for bipolar depression: a 12-month open-label trial.
Milev R; Abraham G; Zaheer J
Can J Psychiatry; 2006 Jul; 51(8):523-30. PubMed ID: 16933589
[TBL] [Abstract][Full Text] [Related]
34. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
[TBL] [Abstract][Full Text] [Related]
35. Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia.
Lee JG; Lee JI; Kim YT; Kim CE; Kim CY; Yoon JS; Yoo SY; Kim YH
Hum Psychopharmacol; 2012 Jul; 27(4):403-10. PubMed ID: 22753400
[TBL] [Abstract][Full Text] [Related]
36. Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study.
Robert S; Hamner MB; Kose S; Ulmer HG; Deitsch SE; Lorberbaum JP
J Clin Psychopharmacol; 2005 Aug; 25(4):387-8. PubMed ID: 16012285
[No Abstract] [Full Text] [Related]
37. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group.
Borison RL; Arvanitis LA; Miller BG
J Clin Psychopharmacol; 1996 Apr; 16(2):158-69. PubMed ID: 8690831
[TBL] [Abstract][Full Text] [Related]
38. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
39. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
40. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms.
Hamner MB; Faldowski RA; Ulmer HG; Frueh BC; Huber MG; Arana GW
Int Clin Psychopharmacol; 2003 Jan; 18(1):1-8. PubMed ID: 12490768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
